-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Integra Lifesciences Holdings Corp quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2010 to 2023.
- Integra Lifesciences Holdings Corp Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was -$2.78M, a 673% decline year-over-year.
- Integra Lifesciences Holdings Corp Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $3.4M, a 86.6% decline year-over-year.
- Integra Lifesciences Holdings Corp annual Income Tax Expense (Benefit) for 2023 was $13.3M, a 60% decline from 2022.
- Integra Lifesciences Holdings Corp annual Income Tax Expense (Benefit) for 2022 was $33.3M, a 26.9% decline from 2021.
- Integra Lifesciences Holdings Corp annual Income Tax Expense (Benefit) for 2021 was $45.6M.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)